MATTHEW SPELLMAN: Open Payments
NPI 1528695996 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 65 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,280
Food & beverage: $1,280
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $213 |
| ABBVIE INC. | 9 | $156 |
| Lilly USA, LLC | 6 | $129 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| Axsome Therapeutics, Inc. | 5 | $97 |
| Astellas Pharma US Inc | 4 | $96 |
| Phathom Pharmaceuticals, Inc. | 6 | $86 |
| SANOFI-AVENTIS U.S. LLC | 2 | $71 |
| Amgen Inc. | 4 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
Products named: Auvelity, Veozah, VOQUEZNA, JARDIANCE, UBRELVY, Ozempic, QULIPTA, TZIELD.
Industry payments across NY — which companies pay providers there.
